Arvato Systems signs deal with SecurMed UK to deliver medicines verification
SecurMed UK, the UK Medicines Verification Organisation, is entering into a Letter of Intent with Arvato Systems as its IT blueprint service provider.
List view / Grid view
SecurMed UK, the UK Medicines Verification Organisation, is entering into a Letter of Intent with Arvato Systems as its IT blueprint service provider.
Twenty-seven Alzheimer's drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years...
Oramed announced today the appointment of Dr Simon Bruce MD to the newly created position of Vice President of Medical Affairs...
A new report shows that the UK is trailing behind the rest of Europe in the diagnosis and treatment of cancer.
Digital risk calculator highlights cyber attacks and highly sensitive or valuable data as major risks for life sciences businesses
A hypoallergenic electronic sensor can be worn on the skin continuously for a week without discomfort, and is so light and thin that users forget they even have it on, says a Japanese group of scientists.
Align Biopharma, an industry technology standards group, introduced 14 leading biopharma companies and technology and service providers as new members.
A comprehensive, international guideline that incorporates the most up-to-date knowledge on diagnosis, treatment and patient impact of Turner syndrome (TS) has been published.
Antalis’ customers are set to benefit from a fleet of more technologically advanced vehicles as part of its £5m partnership with fleet provider, Fraikin...
Wickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of the GLP accreditation...
The LiQuilaz® II builds on the trusted efficiency of the original LiQuilaz configuration, but has expanded features, and RoHS compliancy...
New Uvisel Plus includes the next generation of FastAcq technology with increased measurement accuracy...
Niall Dickson responds to the commitment by the secretaries of state to seek a collaborative relationship with the EU in medicines regulation and supply...
NICE has approved adalimumab (Humira, AbbVie), etanercept (Enbrel, Pfizer) and ustekinumab (Stelara, Janssen) for treating plaque psoriasis in children...
The British National Formulary (BNF) and British National Formulary for Children (BNFC) have launched a new, faster, easier to use app...